The North America Genu Recurvatum Market would witness market growth of 4.8% CAGR during the forecast period (2024-2031).
The US market dominated the North America Genu Recurvatum Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2,502.1 million by 2031. The Canada market is experiencing a CAGR of 6% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 5.8% during (2024 - 2031).
This, also referred to as knee hyperextension, is a musculoskeletal condition that is distinguished by an excessive backward flexion of the knee joint beyond its normal range. This abnormality affects movement and stability, often leading to pain, discomfort, and long-term mobility issues if left untreated. Numerous things, including neurological conditions, traumatic injuries, congenital abnormalities, and difficulties following surgery, might contribute to the illness.
The market for this is expanding as healthcare professionals emphasize early diagnosis and intervention strategies. Previously, many individuals with mild knee hyperextension ignored their symptoms, only seeking medical attention when complications such as joint instability or chronic pain arose. However, early-stage interventions have become more common with increasing awareness campaigns and healthcare initiatives.
This market in North America is experiencing significant growth, driven by factors such as an aging population, increasing prevalence of orthopedic conditions, and advancements in medical technology. The region's well-developed healthcare infrastructure and high adoption of innovative treatments contribute to its leading position in the market. Mexico is experiencing a gradual increase in demand for their treatments, driven by rising awareness of orthopedic health, economic growth, and an expanding middle-class population seeking advanced medical care. Similarly, in Canada, Arthritis Society Canada reported that in 2020, approximately 6 million Canadians had arthritis, and the prevalence is projected to increase by 50% by 2040. This rise correlates with the growing demand for orthopedic care, rehabilitation, and minimally invasive treatments for knee conditions such as genu recurvatum. Hence, with ongoing research in regenerative medicine, AI-driven rehabilitation, and personalized orthopedic solutions, North America is expected to remain a global leader in knee disorder treatments, ensuring better patient outcomes and long-term mobility solutions.
Free Valuable Insights: The Genu Recurvatum Market is Predict to reach USD 8.72 Billion by 2031, at a CAGR of 5.3%
Based on Treatment Type, the market is segmented into Surgical Treatments (Osteotomy, Knee Realignment Surgeries, and Arthroscopy) and Non-Surgical Treatments (Physical Therapy, Bracing & Orthotics, and Rehabilitation Exercises). Based on End User, the market is segmented into Hospitals, Orthopedic Clinics, and Other End User. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Smith & Nephew plc
- Stryker Corporation
- 3M Company
- Zimmer Biomet Holdings, Inc.
- Aspen Medical Products, LLC
- THUASNE
- Bauerfeind AG
- Medi GmbH & Co. KG
- Tynor Orthotics Pvt. Ltd.
North America Genu Recurvatum Market Report Segmentation
By Treatment Type
- Surgical Treatments
- Osteotomy
- Knee Realignment Surgeries
- Arthroscopy
- Non-Surgical Treatments
- Physical Therapy
- Bracing & Orthotics
- Rehabilitation Exercises
By End User
- Hospitals
- Orthopedic Clinics
- Other End User
By Country
- US
- Canada
- Mexico
- Rest of North America
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Genu Recurvatum Market, by Treatment Type
1.4.2 North America Genu Recurvatum Market, by End User
1.4.3 North America Genu Recurvatum Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis – Global
4.1 Market Share Analysis, 2023
4.2 Porter Five Forces Analysis
Chapter 5. North America Genu Recurvatum Market by Treatment Type
5.1 North America Surgical Treatments Market by Region
5.2 North America Genu Recurvatum Market by Surgical Treatments Type
5.2.1 North America Osteotomy Market by Country
5.2.2 North America Knee Realignment Surgeries Market by Country
5.2.3 North America Arthroscopy Market by Country
5.3 North America Non-Surgical Treatments Market by Region
5.4 North America Genu Recurvatum Market by Non-Surgical Treatments Type
5.4.1 North America Physical Therapy Market by Country
5.4.2 North America Bracing & Orthotics Market by Country
5.4.3 North America Rehabilitation Exercises Market by Country
Chapter 6. North America Genu Recurvatum Market by End User
6.1 North America Hospitals Market by Country
6.2 North America Orthopedic Clinics Market by Country
6.3 North America Other End User Market by Country
Chapter 7. North America Genu Recurvatum Market by Country
7.1 US Genu Recurvatum Market
7.1.1 US Genu Recurvatum Market by Treatment Type
7.1.1.1 US Genu Recurvatum Market by Surgical Treatments Type
7.1.1.2 US Genu Recurvatum Market by Non-Surgical Treatments Type
7.1.2 US Genu Recurvatum Market by End User
7.2 Canada Genu Recurvatum Market
7.2.1 Canada Genu Recurvatum Market by Treatment Type
7.2.1.1 Canada Genu Recurvatum Market by Surgical Treatments Type
7.2.1.2 Canada Genu Recurvatum Market by Non-Surgical Treatments Type
7.2.2 Canada Genu Recurvatum Market by End User
7.3 Mexico Genu Recurvatum Market
7.3.1 Mexico Genu Recurvatum Market by Treatment Type
7.3.1.1 Mexico Genu Recurvatum Market by Surgical Treatments Type
7.3.1.2 Mexico Genu Recurvatum Market by Non-Surgical Treatments Type
7.3.2 Mexico Genu Recurvatum Market by End User
7.4 Rest of North America Genu Recurvatum Market
7.4.1 Rest of North America Genu Recurvatum Market by Treatment Type
7.4.1.1 Rest of North America Genu Recurvatum Market by Surgical Treatments Type
7.4.1.2 Rest of North America Genu Recurvatum Market by Non-Surgical Treatments Type
7.4.2 Rest of North America Genu Recurvatum Market by End User
Chapter 8. Company Profiles
8.1 Smith & Nephew PLC
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional and Segmental Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Stryker Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 3M Company
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Zimmer Biomet Holdings, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 Aspen Medical Products, LLC
8.5.1 Company Overview
8.6 THUASNE
8.6.1 Company Overview
8.7 Bauerfeind AG
8.7.1 Company Overview
8.8 Medi GmbH & Co. KG
8.8.1 Company Overview
8.9 Tynor Orthotics Pvt. Ltd.
8.9.1 Company Overview
TABLE 1 North America Genu Recurvatum Market, 2020 - 2023, USD Million
TABLE 2 North America Genu Recurvatum Market, 2024 - 2031, USD Million
TABLE 3 North America Genu Recurvatum Market by Treatment Type, 2020 - 2023, USD Million
TABLE 4 North America Genu Recurvatum Market by Treatment Type, 2024 - 2031, USD Million
TABLE 5 North America Surgical Treatments Market by Region, 2020 - 2023, USD Million
TABLE 6 North America Surgical Treatments Market by Region, 2024 - 2031, USD Million
TABLE 7 North America Genu Recurvatum Market by Surgical Treatments Type, 2020 - 2023, USD Million
TABLE 8 North America Genu Recurvatum Market by Surgical Treatments Type, 2024 - 2031, USD Million
TABLE 9 North America Osteotomy Market by Country, 2020 - 2023, USD Million
TABLE 10 North America Osteotomy Market by Country, 2024 - 2031, USD Million
TABLE 11 North America Knee Realignment Surgeries Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Knee Realignment Surgeries Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Arthroscopy Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Arthroscopy Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Non-Surgical Treatments Market by Region, 2020 - 2023, USD Million
TABLE 16 North America Non-Surgical Treatments Market by Region, 2024 - 2031, USD Million
TABLE 17 North America Genu Recurvatum Market by Non-Surgical Treatments Type, 2020 - 2023, USD Million
TABLE 18 North America Genu Recurvatum Market by Non-Surgical Treatments Type, 2024 - 2031, USD Million
TABLE 19 North America Physical Therapy Market by Country, 2020 - 2023, USD Million
TABLE 20 North America Physical Therapy Market by Country, 2024 - 2031, USD Million
TABLE 21 North America Bracing & Orthotics Market by Country, 2020 - 2023, USD Million
TABLE 22 North America Bracing & Orthotics Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Rehabilitation Exercises Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Rehabilitation Exercises Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Genu Recurvatum Market by End User, 2020 - 2023, USD Million
TABLE 26 North America Genu Recurvatum Market by End User, 2024 - 2031, USD Million
TABLE 27 North America Hospitals Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Hospitals Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Orthopedic Clinics Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Orthopedic Clinics Market by Country, 2024 - 2031, USD Million
TABLE 31 North America Other End User Market by Country, 2020 - 2023, USD Million
TABLE 32 North America Other End User Market by Country, 2024 - 2031, USD Million
TABLE 33 North America Genu Recurvatum Market by Country, 2020 - 2023, USD Million
TABLE 34 North America Genu Recurvatum Market by Country, 2024 - 2031, USD Million
TABLE 35 US Genu Recurvatum Market, 2020 - 2023, USD Million
TABLE 36 US Genu Recurvatum Market, 2024 - 2031, USD Million
TABLE 37 US Genu Recurvatum Market by Treatment Type, 2020 - 2023, USD Million
TABLE 38 US Genu Recurvatum Market by Treatment Type, 2024 - 2031, USD Million
TABLE 39 US Genu Recurvatum Market by Surgical Treatments Type, 2020 - 2023, USD Million
TABLE 40 US Genu Recurvatum Market by Surgical Treatments Type, 2024 - 2031, USD Million
TABLE 41 US Genu Recurvatum Market by Non-Surgical Treatments Type, 2020 - 2023, USD Million
TABLE 42 US Genu Recurvatum Market by Non-Surgical Treatments Type, 2024 - 2031, USD Million
TABLE 43 US Genu Recurvatum Market by End User, 2020 - 2023, USD Million
TABLE 44 US Genu Recurvatum Market by End User, 2024 - 2031, USD Million
TABLE 45 Canada Genu Recurvatum Market, 2020 - 2023, USD Million
TABLE 46 Canada Genu Recurvatum Market, 2024 - 2031, USD Million
TABLE 47 Canada Genu Recurvatum Market by Treatment Type, 2020 - 2023, USD Million
TABLE 48 Canada Genu Recurvatum Market by Treatment Type, 2024 - 2031, USD Million
TABLE 49 Canada Genu Recurvatum Market by Surgical Treatments Type, 2020 - 2023, USD Million
TABLE 50 Canada Genu Recurvatum Market by Surgical Treatments Type, 2024 - 2031, USD Million
TABLE 51 Canada Genu Recurvatum Market by Non-Surgical Treatments Type, 2020 - 2023, USD Million
TABLE 52 Canada Genu Recurvatum Market by Non-Surgical Treatments Type, 2024 - 2031, USD Million
TABLE 53 Canada Genu Recurvatum Market by End User, 2020 - 2023, USD Million
TABLE 54 Canada Genu Recurvatum Market by End User, 2024 - 2031, USD Million
TABLE 55 Mexico Genu Recurvatum Market, 2020 - 2023, USD Million
TABLE 56 Mexico Genu Recurvatum Market, 2024 - 2031, USD Million
TABLE 57 Mexico Genu Recurvatum Market by Treatment Type, 2020 - 2023, USD Million
TABLE 58 Mexico Genu Recurvatum Market by Treatment Type, 2024 - 2031, USD Million
TABLE 59 Mexico Genu Recurvatum Market by Surgical Treatments Type, 2020 - 2023, USD Million
TABLE 60 Mexico Genu Recurvatum Market by Surgical Treatments Type, 2024 - 2031, USD Million
TABLE 61 Mexico Genu Recurvatum Market by Non-Surgical Treatments Type, 2020 - 2023, USD Million
TABLE 62 Mexico Genu Recurvatum Market by Non-Surgical Treatments Type, 2024 - 2031, USD Million
TABLE 63 Mexico Genu Recurvatum Market by End User, 2020 - 2023, USD Million
TABLE 64 Mexico Genu Recurvatum Market by End User, 2024 - 2031, USD Million
TABLE 65 Rest of North America Genu Recurvatum Market, 2020 - 2023, USD Million
TABLE 66 Rest of North America Genu Recurvatum Market, 2024 - 2031, USD Million
TABLE 67 Rest of North America Genu Recurvatum Market by Treatment Type, 2020 - 2023, USD Million
TABLE 68 Rest of North America Genu Recurvatum Market by Treatment Type, 2024 - 2031, USD Million
TABLE 69 Rest of North America Genu Recurvatum Market by Surgical Treatments Type, 2020 - 2023, USD Million
TABLE 70 Rest of North America Genu Recurvatum Market by Surgical Treatments Type, 2024 - 2031, USD Million
TABLE 71 Rest of North America Genu Recurvatum Market by Non-Surgical Treatments Type, 2020 - 2023, USD Million
TABLE 72 Rest of North America Genu Recurvatum Market by Non-Surgical Treatments Type, 2024 - 2031, USD Million
TABLE 73 Rest of North America Genu Recurvatum Market by End User, 2020 - 2023, USD Million
TABLE 74 Rest of North America Genu Recurvatum Market by End User, 2024 - 2031, USD Million
TABLE 75 Key Information – Smith & Nephew PLC
TABLE 76 Key Information – Stryker Corporation
TABLE 77 Key Information – 3M Company
TABLE 78 Key Information – Zimmer Biomet Holdings, Inc.
TABLE 79 Key Information – Aspen Medical Products, LLC
TABLE 80 Key Information – THUASNE
TABLE 81 Key Information – Bauerfeind AG
TABLE 82 Key Information – Medi GmbH & Co. KG
TABLE 83 Key Information – Tynor Orthotics Pvt. Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Genu Recurvatum Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Genu Recurvatum Market
FIG 4 Market Share Analysis, 2023
FIG 5 Porter’s Five Forces Analysis – Genu Recurvatum Market
FIG 6 North America Genu Recurvatum Market share by Treatment Type, 2023
FIG 7 North America Genu Recurvatum Market share by Treatment Type, 2031
FIG 8 North America Genu Recurvatum Market by Treatment Type, 2020 - 2031, USD Million
FIG 9 North America Genu Recurvatum Market share by End User, 2023
FIG 10 North America Genu Recurvatum Market share by End User, 2031
FIG 11 North America Genu Recurvatum Market by End User, 2020 - 2031, USD Million
FIG 12 North America Genu Recurvatum Market share by Country, 2023
FIG 13 North America Genu Recurvatum Market share by Country, 2031
FIG 14 North America Genu Recurvatum Market by Country, 2020 - 2031, USD Million
FIG 15 SWOT Analysis: Smith & Nephew PLC
FIG 16 SWOT Analysis: Stryker Corporation
FIG 17 SWOT Analysis: 3M Company
FIG 18 SWOT Analysis: Zimmer Biomet Holdings, Inc.